If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.50 (1.01%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £95.93m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Change in Reporting Currency

2 May 2013 07:00

RNS Number : 8119D
Iofina PLC
02 May 2013
 



 

 

2 May 2013

 

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Change in Reporting Currency

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, announces that following consultation with its major shareholders, the Directors have decided to change the Company's reporting currency from Sterling to US Dollars. The Directors believe that, as the functional currency of the Company is US Dollars the change will allow for greater transparency and limit exchange rate risk experienced by the Company.

 

The change in the Company's reporting currency will be effective from the results for the year ending 31 December 2012. These results and all subsequent financial information for the foreseeable future will be prepared using US Dollars as the presentation currency. In accordance with relevant accounting standards, comparative information will be provided in US Dollars. 

 

 

About Iofina

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.  

 

For further information, please contact:

 

Dr Chris Fay, Executive Chairman

Stuart Eaton, Executive Operations Director

Iofina plc

Tel: +44(0)20 3006 3135

 www.iofina.com

 

Ben Colegrave/Chris Sim/Neil Elliot

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUQAAUPWPUG
Date   Source Headline
10th Aug 200911:13 amRNSManagement Appointments
27th Jul 20097:00 amRNSAcquisition and Operations Update
23rd Jun 200910:20 amRNSResult of AGM
22nd Jun 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jun 20094:35 pmRNSPrice Monitoring Extension
27th May 20094:19 pmRNSPosting of Annual Report
12th May 20097:00 amRNSFinal Results
25th Feb 20099:57 amRNSHolding(s) in Company
23rd Feb 20091:55 pmRNSHolding(s) in Company
19th Feb 200911:06 amRNSDirector/PDMR Shareholding
12th Feb 20094:44 pmRNSPlacing
13th Jan 20097:00 amRNSDirectorate Change
13th Jan 20097:00 amRNSDrilling Update
19th Dec 20085:00 pmRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSOperational Update
7th Nov 20089:59 amRNSHolding(s) in Company
31st Oct 200810:53 amRNSDirector/PDMR Shareholding
30th Oct 20083:39 pmRNSHolding(s) in Company
16th Sep 20085:26 pmRNSDirector/PDMR Shareholding
16th Sep 20084:28 pmRNSDirector/PDMR Shareholding
12th Sep 20085:03 pmRNSDirectorate Change
9th Sep 20087:00 amRNSAppointment of Non Executive
9th Sep 20087:00 amRNSInterim Results
13th Aug 20087:00 amRNSAcquisition
25th Jul 20085:10 pmRNSHolding(s) in Company
16th Jul 20087:00 amRNSOperations Update
10th Jun 20081:29 pmBUSRule 8.3 - INFORMA PLC
9th May 20087:00 amRNSPlacing and Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.